Form 4 Tracker
Eton Pharmaceuticals, Inc.
ETON

19 insider filings · Latest: Jul 31, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jul 14, 2026Jul 17 11:12 PMOpaleye Management Inc.10% Owner
Sale
28,315$37.54$1.1M40,000(I)

View →

Jul 14, 2026Jul 16 9:14 PMOpaleye Management Inc.10% Owner
Sale
28,315$37.54$1.1M40,000(I)

View →

Jul 7, 2026Jul 7 10:29 PMOpaleye Management Inc.10% Owner
Sale
26,685$38.37$1.0M53,315(I)

View →

Jul 6, 2026Jul 7 10:29 PMOpaleye Management Inc.10% Owner
Sale
10,000$38.00$380.0K2,700,000(I)

View →

Jul 2, 2026Jul 7 10:29 PMOpaleye Management Inc.10% Owner
Sale
90,000$37.39$3.4M60,000(I)

View →

Jun 26, 2026Jun 26 8:14 PMGruber James R.
Proposed Sale
251,818$35.70$9.0M

View →

Jun 25, 2026Jun 25 8:12 PMGruber James R.
Proposed Sale
25,000$35.01$875.3K

View →

Jun 23, 2026Jun 23 8:32 PMGruber James R.
Proposed Sale
25,000$33.23$830.9K

View →

Jun 17, 2026Jun 17 9:08 PMJennifer Mckie AdamsDirector
Sale
50,000$32.48$1.6M0(D)

View →

Jun 17, 2026Jun 17 3:43 PMAdams Jennifer McKie
Proposed Sale
50,000$32.37$1.6M

View →

Jun 2, 2026Jun 2 8:48 PMGruber James R.
Proposed Sale
3,117$27.00$84.2K

View →

May 28, 2026May 29 8:16 PMBRYNJELSEN SEANDirector, President & CEO
Sale
120,000$31.88$3.8M833,694(D)

View →

May 28, 2026May 28 7:12 PMBRYNJELSEN SEAN
Proposed Sale
120,000$32.40$3.9M

View →

May 27, 2026May 27 10:28 PMDavid KrempaChief Business Officer
Sale
19,679$31.47$619.4K25,249(D)

View →

May 26, 2026May 27 10:28 PMDavid KrempaChief Business Officer
Sale
37,524$31.49$1.2M25,249(D)

View →

May 22, 2026May 27 10:28 PMDavid KrempaChief Business Officer
Sale
42,797$33.39$1.4M25,249(D)

View →

May 22, 2026May 22 8:24 PMKrempa David
Proposed Sale
100,000$35.00$3.5M

View →

Jan 14, 2026Jan 14 10:17 PMKrempa David
Proposed Sale
1,942$15.62$30.3K

View →

Jan 14, 2026Jan 14 10:09 PMGruber James R.
Proposed Sale
2,293$15.47$35.5K

View →

Jan 14, 2026Jan 14 4:28 PMBRYNJELSEN SEAN
Proposed Sale
5,015$15.39$77.2K

View →

Page 1 of 2

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jul 31, 2026Aug 4 9:10 PMCharles J CasamentoDirector
Grant/Award
10,00010,000(D)

View →

Jul 31, 2026Aug 4 9:04 PMJudith M. MatthewsChief Financial Officer
Grant/Award
32,24632,246(D)

View →

Jul 31, 2026Aug 4 9:03 PMIpek Erdogan-TrinkausChief Commercial Officer
Grant/Award
80,00080,000(D)

View →

Jul 31, 2026Aug 4 9:01 PMBRYNJELSEN SEANDirector, President & CEO
Grant/Award
128,985128,985(D)

View →

Jul 31, 2026Aug 4 9:01 PMDavid KrempaChief Business Officer
Grant/Award
128,985128,985(D)

View →

Jul 31, 2026Aug 4 8:57 PMPaul V MaierDirector
Grant/Award
10,00010,000(D)

View →

Jul 31, 2026Aug 4 8:56 PMNorbert G RiedelDirector
Grant/Award
10,00010,000(D)

View →

Jul 31, 2026Aug 4 8:55 PMJennifer Mckie AdamsDirector
Grant/Award
10,00010,000(D)

View →

Jul 14, 2026Jul 14 9:28 PMBRYNJELSEN SEANDirector, President & CEO
Option Exercise
200,000$1.370(D)

View →

Jul 12, 2026Jul 14 9:28 PMBRYNJELSEN SEANDirector, President & CEO
Option Exercise
27,500$0.000(D)

View →

Jul 12, 2026Jul 13 8:36 PMDavid KrempaChief Business Officer
Option Exercise
10,000$0.000(D)

View →

Jun 26, 2026Jun 30 8:27 PMDavid KrempaChief Business Officer
Grant/Award
10,00096,829(D)

View →

Jun 17, 2026Jun 17 9:08 PMJennifer Mckie AdamsDirector
Option Exercise
50,000$3.780(D)

View →

May 27, 2026May 27 10:28 PMDavid KrempaChief Business Officer
Option Exercise
19,679$3.58118,406(D)

View →

May 26, 2026May 27 10:28 PMDavid KrempaChief Business Officer
Option Exercise
37,524$1.3812,476(D)

View →

May 22, 2026May 27 10:28 PMDavid KrempaChief Business Officer
Option Exercise
30,591$3.58125,609(D)

View →

Apr 21, 2026Apr 22 8:40 PMNorbert G RiedelDirector
Option Exercise
32,155$8.610(D)

View →

Feb 3, 2026Feb 5 10:18 PMNorbert G RiedelDirector
X
30,000$4.420(D)

View →